Relationship between activation of epidermal growth factor receptor and cell dissociation in pancreatic cancer

被引:1
|
作者
Tan, XD [1 ]
Egami, H [1 ]
Ishikawa, S [1 ]
Nakagawa, M [1 ]
Ishiko, T [1 ]
Kamohara, H [1 ]
Hirota, M [1 ]
Ogawa, M [1 ]
机构
[1] Kumamoto Univ, Sch Med, Dept Surg 2, Kumamoto 8608556, Japan
关键词
epidermal growth factor receptor; dissociation factor; cell dissociation; pancreatic cancer;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In our previous investigations, mitogen-activated protein kinase kinase 2 (MEK2)/extracellular signal-regulated kinase 2 (ERK2) signaling pathway was found to be correlated with the cell dissociation induced by dissociation factor (DF) in pancreatic cancer cells. In this study, the expressions of epidermal growth factor receptor (EGFR), phosphorylated EGFR (p-EGFR), and its downstream kinases MEK1/2 and ERK1/2, were analyzed to clarify the regulatory mechanism of cell dissociation in pancreatic cancer cells. Two hamster (PC-1.0 and PC-1) and two human (AsPC-1 and Capan-2) pancreatic cancer cell lines, were used. Immunocytochemical study was performed using anti-EGFR, p-EGFR, phosphorylated MEK1/2 (p-MEK1/2), and phosphorylated ERK1/2 (p-ERK1/2) antibodies. DF-treatment markedly induced the expressions of EGFR, p-EGFR, p-MEK1/2, p-ERK1/2, as well as the dissociation of cell colonies in PC-I and Capan-2 cells. In contrast, AG1478 (an EGFR inhibitor) treatment significantly induced the cell aggregation in PC-1.0 and AsPC-1 cells which usually grew as single cells, but strongly suppressed the expressions of EGFR, p-EGFR, p-MEK1/2, and p-ERK1/2. These observations demonstrate that activation of EGFR is closely involved in cell dissociation in pancreatic cancer through activating MEK/ERK signaling pathway.
引用
收藏
页码:1303 / 1309
页数:7
相关论文
共 50 条
  • [21] Potential crosstalk between insulin-like growth factor receptor type 1 and epidermal growth factor receptor in progression and metastasis of pancreatic cancer
    Ueda, Shigeto
    Hatsuse, Kazuo
    Tsuda, Hitoshi
    Ogata, Sho
    Kawarabayashi, Nobuaki
    Takigawa, Toshimichi
    Einama, Takahiro
    Morita, Daisaku
    Fukatsu, Kazuhiko
    Sugiura, Yoshiaki
    Matsubara, Osamu
    Mochizuki, Hidetaka
    MODERN PATHOLOGY, 2006, 19 (06) : 788 - 796
  • [22] Epidermal growth factor receptor influences the antigen presentation pathway in pancreatic cancer
    Knoche, S.
    Solheim, J.
    EUROPEAN JOURNAL OF CANCER, 2020, 138 : S60 - S61
  • [23] Treatment of pancreatic cancer with epidermal growth factor receptor-targeted therapy
    Faller, Bryan A.
    Burtness, Barbara
    BIOLOGICS-TARGETS & THERAPY, 2009, 3 : 419 - 428
  • [24] Epidermal growth factor receptor expression and tumor immune microenvironment in pancreatic cancer
    Shibahara, Yu
    Yasunaga, Masahiro
    CANCER SCIENCE, 2025, 116 : 1021 - 1021
  • [25] The combination of epidermal growth factor receptor inhibitors with gemcitabine and radiation in pancreatic cancer
    Morgan, Meredith A.
    Parsels, Leslie A.
    Kollar, Laura E.
    Normolle, Daniel P.
    Maybaum, Jonathan
    Lawrence, Theodore S.
    CLINICAL CANCER RESEARCH, 2008, 14 (16) : 5142 - 5149
  • [26] Epidermal growth factor receptor gene is highly conserved in pancreatic cancer cells
    Mimori, K
    Nagahara, H
    Barnard, GF
    Mori, M
    PANCREAS, 2005, 31 (03) : 299 - 299
  • [27] Epidermal-growth factor receptor (EGFR) is highly conserved in pancreatic cancer
    Tzeng, Ching-Wei D.
    Frolov, Andrey
    Frolova, Natalya
    Jhala, Nirag C.
    Howard, J. Harrison
    Buchsbaum, Donald J.
    Vickers, Selwyn M.
    Heslin, Martin J.
    Arnoletti, J. Pablo
    SURGERY, 2007, 141 (04) : 464 - 469
  • [28] Activated Epidermal Growth Factor Receptor as a Novel Target in Pancreatic Cancer Therapy
    Harsha, H. C.
    Jimeno, Antonio
    Molina, Henrik
    Mihalas, Anca B.
    Goggins, Michael G.
    Hruban, Ralph H.
    Schulick, Richard D.
    Kamath, Ullas
    Maltra, Anirban
    Hidalgo, Manuel
    Pandey, Akhilesh
    JOURNAL OF PROTEOME RESEARCH, 2008, 7 (11) : 4651 - 4658
  • [29] Clinicopathological significance of epidermal growth factor and its receptor in human pancreatic cancer
    Uegaki, K
    Nio, Y
    Inoue, Y
    Minari, Y
    Sato, Y
    Song, MM
    Dong, M
    Tamura, K
    ANTICANCER RESEARCH, 1997, 17 (5B) : 3841 - 3847
  • [30] Defining the role of the epidermal growth factor receptor in pancreatic cancer grown in vitro
    Durkin, AJ
    Bloomston, PM
    Rosemurgy, AS
    Giarelli, N
    Cojita, D
    Yeatman, TJ
    Zervos, EE
    AMERICAN JOURNAL OF SURGERY, 2003, 186 (05): : 431 - 436